Stericycle (NASDAQ:SRCL) was upgraded by research analysts at Robert W. Baird from an “underperform” rating to a “neutral” rating in a research note issued to investors on Tuesday. The brokerage presently has a $73.00 target price on the business services provider’s stock. Robert W. Baird’s target price suggests a potential downside of 1.74% from the company’s previous close.

Other equities analysts have also issued research reports about the stock. Stifel Nicolaus reissued a “buy” rating and issued a $85.00 price target (down previously from $95.00) on shares of Stericycle in a report on Thursday, November 9th. Jefferies Group set a $108.00 price target on shares of Stericycle and gave the company a “buy” rating in a report on Tuesday, October 17th. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 10th. BidaskClub raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, December 20th. Finally, Oppenheimer reissued a “hold” rating on shares of Stericycle in a report on Wednesday, December 13th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $73.70.

Shares of Stericycle (NASDAQ SRCL) opened at $74.29 on Tuesday. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.93. Stericycle has a fifty-two week low of $61.25 and a fifty-two week high of $88.00. The company has a market cap of $6,340.00, a price-to-earnings ratio of -132.66, a price-to-earnings-growth ratio of 1.73 and a beta of 0.26.

In related news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction on Monday, November 27th. The shares were sold at an average price of $63.33, for a total value of $1,250,957.49. Following the completion of the transaction, the director now directly owns 205,854 shares of the company’s stock, valued at approximately $13,036,733.82. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 3.50% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Sentry Investment Management LLC boosted its stake in Stericycle by 1.1% in the 2nd quarter. Sentry Investment Management LLC now owns 6,418 shares of the business services provider’s stock worth $490,000 after purchasing an additional 70 shares during the period. Raymond James Financial Services Advisors Inc. boosted its stake in Stericycle by 2.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 14,593 shares of the business services provider’s stock worth $1,114,000 after purchasing an additional 371 shares during the period. Community Financial Services Group LLC boosted its stake in Stericycle by 1.5% in the 4th quarter. Community Financial Services Group LLC now owns 53,975 shares of the business services provider’s stock worth $3,669,000 after purchasing an additional 795 shares during the period. California State Teachers Retirement System boosted its stake in Stericycle by 0.6% in the 4th quarter. California State Teachers Retirement System now owns 138,949 shares of the business services provider’s stock worth $9,447,000 after purchasing an additional 815 shares during the period. Finally, Armstrong Henry H Associates Inc. boosted its stake in Stericycle by 6.9% in the 4th quarter. Armstrong Henry H Associates Inc. now owns 12,830 shares of the business services provider’s stock worth $872,000 after purchasing an additional 830 shares during the period. 94.24% of the stock is owned by hedge funds and other institutional investors.

WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2018/02/15/stericycle-srcl-raised-to-neutral-at-robert-w-baird.html.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.